Reducing the Hypomania Checklist (HCL-32) to a 16-item version

Area of Science:

• Psychiatry and Mental Health
• Diagnostic Screening Tools
• Bipolar Disorder Research

Background:

• Under-recognition of hypomanic symptoms leads to misdiagnosis and delayed treatment in bipolar disorder (BD).
• Validated screening instruments like the Hypomania Checklist (HCL-32) aim to improve BD detection.
• Assessing the efficacy of a shortened HCL version is crucial for clinical utility.

Purpose of the Study:

• To determine if the Hypomania Checklist (HCL-32) can be shortened without compromising its ability to differentiate bipolar disorder (BD) from major depressive disorder (MDD).
• To evaluate the diagnostic performance of a reduced-item HCL screening tool.
• To explore the potential of a brief HCL version for use in clinical settings.

Main Methods:

• Item correlation analysis was performed on large samples of patients with DSM-IV defined bipolar I disorder (BD-I) (n=230) and recurrent major depressive disorder (MDD) (n=322) to identify redundant items in the HCL-32.
• The performance of a newly developed 16-item HCL (HCL-16) was tested in a separate sample comprising patients with BD (n=59) and MDD (n=76).
• Factor analysis of the HCL-16 identified two primary factors: 'active-elated' and 'risk-taking/irritable'.

Main Results:

• The 16-item HCL (HCL-16) demonstrated a two-factor structure comparable to the full HCL-32.
• A cutoff score of 8 or higher on the HCL-16 showed excellent ability to distinguish between BD and MDD.
• The HCL-16 achieved high sensitivity (83%) and specificity (71%), closely mirroring the performance of the full HCL-32.

Conclusions:

• The shortened 16-item Hypomania Checklist (HCL-16) is a potentially valuable screening tool for hypomania.
• The HCL-16 demonstrates strong potential for use in busy clinical environments to aid in the detection of bipolar disorder.
• Further validation of the HCL-16 as a stand-alone screening instrument is warranted.